These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24080640)

  • 1. Cholesteryl ester transfer protein polymorphisms, statin use, and their impact on cholesterol levels and cardiovascular events.
    Leusink M; Onland-Moret NC; Asselbergs FW; Ding B; Kotti S; van Zuydam NR; Papp AC; Danchin N; Donnelly L; Morris AD; Chasman DI; Doevendans PA; Klungel OH; Ridker PM; van Gilst WH; Simon T; Nyberg F; Palmer CN; Sadee W; van der Harst P; de Bakker PI; de Boer A; Verstuyft C; Maitland-van der Zee AH
    Clin Pharmacol Ther; 2014 Mar; 95(3):314-20. PubMed ID: 24080640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.
    Poduri A; Khullar M; Bahl A; Sehrawat BS; Sharma Y; Talwar KK
    DNA Cell Biol; 2010 Oct; 29(10):629-37. PubMed ID: 20578904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults.
    Millwood IY; Bennett DA; Holmes MV; Boxall R; Guo Y; Bian Z; Yang L; Sansome S; Chen Y; Du H; Yu C; Hacker A; Reilly DF; Tan Y; Hill MR; Chen J; Peto R; Shen H; Collins R; Clarke R; Li L; Walters RG; Chen Z;
    JAMA Cardiol; 2018 Jan; 3(1):34-43. PubMed ID: 29141072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity modifies the effect of LPL, LIPC, and CETP polymorphisms on HDL-C levels and the risk of myocardial infarction in women of European ancestry.
    Ahmad T; Chasman DI; Buring JE; Lee IM; Ridker PM; Everett BM
    Circ Cardiovasc Genet; 2011 Feb; 4(1):74-80. PubMed ID: 21252145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study).
    Khera AV; Wolfe ML; Cannon CP; Qin J; Rader DJ
    Am J Cardiol; 2010 Aug; 106(4):451-6. PubMed ID: 20691300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesteryl Ester Transfer Protein (CETP) polymorphisms affect mRNA splicing, HDL levels, and sex-dependent cardiovascular risk.
    Papp AC; Pinsonneault JK; Wang D; Newman LC; Gong Y; Johnson JA; Pepine CJ; Kumari M; Hingorani AD; Talmud PJ; Shah S; Humphries SE; Sadee W
    PLoS One; 2012; 7(3):e31930. PubMed ID: 22403620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia: a systematic review and meta-analysis.
    Li C; Zhang W; Zhou F; Chen C; Zhou L; Li Y; Liu L; Pei F; Luo H; Hu Z; Cai J; Zeng C
    PLoS One; 2013; 8(10):e77049. PubMed ID: 24204732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF; Muhlestein JB; Horne BD; Hart NI; Bair TL; Molhuizen HO; Anderson JL
    Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in cholesterol ester transfer protein, serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort.
    Schierer A; Been LF; Ralhan S; Wander GS; Aston CE; Sanghera DK
    Pharmacogenet Genomics; 2012 Feb; 22(2):95-104. PubMed ID: 22143414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
    Boekholdt SM; Sacks FM; Jukema JW; Shepherd J; Freeman DJ; McMahon AD; Cambien F; Nicaud V; de Grooth GJ; Talmud PJ; Humphries SE; Miller GJ; Eiriksdottir G; Gudnason V; Kauma H; Kakko S; Savolainen MJ; Arca M; Montali A; Liu S; Lanz HJ; Zwinderman AH; Kuivenhoven JA; Kastelein JJ
    Circulation; 2005 Jan; 111(3):278-87. PubMed ID: 15655129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of genome-wide association studies of HDL cholesterol response to statins.
    Postmus I; Warren HR; Trompet S; Arsenault BJ; Avery CL; Bis JC; Chasman DI; de Keyser CE; Deshmukh HA; Evans DS; Feng Q; Li X; Smit RA; Smith AV; Sun F; Taylor KD; Arnold AM; Barnes MR; Barratt BJ; Betteridge J; Boekholdt SM; Boerwinkle E; Buckley BM; Chen YI; de Craen AJ; Cummings SR; Denny JC; Dubé MP; Durrington PN; Eiriksdottir G; Ford I; Guo X; Harris TB; Heckbert SR; Hofman A; Hovingh GK; Kastelein JJ; Launer LJ; Liu CT; Liu Y; Lumley T; McKeigue PM; Munroe PB; Neil A; Nickerson DA; Nyberg F; O'Brien E; O'Donnell CJ; Post W; Poulter N; Vasan RS; Rice K; Rich SS; Rivadeneira F; Sattar N; Sever P; Shaw-Hawkins S; Shields DC; Slagboom PE; Smith NL; Smith JD; Sotoodehnia N; Stanton A; Stott DJ; Stricker BH; Stürmer T; Uitterlinden AG; Wei WQ; Westendorp RG; Whitsel EA; Wiggins KL; Wilke RA; Ballantyne CM; Colhoun HM; Cupples LA; Franco OH; Gudnason V; Hitman G; Palmer CN; Psaty BM; Ridker PM; Stafford JM; Stein CM; Tardif JC; Caulfield MJ; Jukema JW; Rotter JI; Krauss RM
    J Med Genet; 2016 Dec; 53(12):835-845. PubMed ID: 27587472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesteryl ester transfer protein rs1532624 gene polymorphism is associated with reduced response to statin therapy.
    Yehya A; Irshaid Y; Saleh AA
    Curr Mol Pharmacol; 2013 Nov; 6(3):156-62. PubMed ID: 24160573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study.
    Ridker PM; Paré G; Parker AN; Zee RY; Miletich JP; Chasman DI
    Circ Cardiovasc Genet; 2009 Feb; 2(1):26-33. PubMed ID: 20031564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic study of statin therapy and cholesterol reduction.
    Chasman DI; Posada D; Subrahmanyan L; Cook NR; Stanton VP; Ridker PM
    JAMA; 2004 Jun; 291(23):2821-7. PubMed ID: 15199031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients.
    Keene D; Price C; Shun-Shin MJ; Francis DP
    BMJ; 2014 Jul; 349():g4379. PubMed ID: 25038074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The loss-of-function mutation of CETP affects HDLc levels but not ApoA1 in patients with acute myocardial infarction.
    Li W; Liu X; Huang C; Liu L; Tan X; Wang X
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):602-607. PubMed ID: 33358712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.
    Le Goff W; Guerin M; Nicaud V; Dachet C; Luc G; Arveiler D; Ruidavets JB; Evans A; Kee F; Morrison C; Chapman MJ; Thillet J
    Atherosclerosis; 2002 Apr; 161(2):269-79. PubMed ID: 11888509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk.
    Jafri H; Alsheikh-Ali AA; Karas RH
    Ann Intern Med; 2010 Dec; 153(12):800-8. PubMed ID: 21173414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
    Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
    PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol levels and the association of statins with in-hospital mortality of myocardial infarction patients insights from a Chilean registry of myocardial infarction.
    Martínez G; Rigotti A; Acevedo M; Navarrete C; Rosales J; Giugliano RP; Corbalán R
    Clin Cardiol; 2013 Jun; 36(6):305-11. PubMed ID: 23494544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.